Australia Health authorities confident woman's death nothing to do with vaccine
How mRNA Technology Could Change the World
mRNA’s story likely will not end with COVID-19: Its potential stretches far beyond this pandemic. This year, a team at Yale patented a similar RNA-based technology to vaccinate against malaria, perhaps the world’s most devastating disease. Because mRNA is so easy to edit, Pfizer says that it is planning to use it against seasonal flu, which mutates constantly and kills hundreds of thousands of people around the world every year.
Health authorities believe the death of a woman just hours after she received a Covid -19 vaccination was unrelated to the injection.
The 82-year-old died at the Blue Care Yurana Aged Care Facility in the southern Brisbane suburb of Springwood on Wednesday, reportedly three hours after being given the Pfizer vaccine.
As of Wednesday evening there were no signs of any link between the woman's death and the vaccination, according to Australia's Chief Medical Officer, Professor Paul Kelly.
The woman is understood to have been suffering from a lung disease.
Why Hong Kongers Are Slow to Get a Vaccine
As a result of mass alienation among the population, the city views its leadership with intense suspicion.Now, however, the city is having trouble getting the public to take part in its vaccination drive, an effort hampered in large part by deep suspicion of the government and a historically unpopular leader who has struggled mightily to convince the public of the benefits of getting inoculated. An abundance of vaccines, officials are discovering, means very little when trust is in such short supply.
'Sadly more than 1000 people pass in aged care every week. It is inevitable that this will include people who have been recently vaccinated,' Professor Kelly said.
'It can be expected that older and more frail people in an aged care setting may pass away due to progression of underlying disease or natural causes, this does not mean the vaccine has contributed to this.'
He added that 'any event' occurring after a vaccination will be 'fully investigated' by medical experts and the Therapeutic Goods Administration.
A report is also being prepared for the coroner.
Police were called to the residence at 1.30pm and confirmed to Daily Mail Australia that the woman's death 'is not being treated as suspicious'.
Queensland Police were unable to comment further.
Australian man, 44, hospitalised with blood costs after Covid vaccine
The 44-year-old got the jab on March 22 and later presented to a Melbourne hospital suffering fever and abdominal pain, and was found to have blood clots in his abdomen.The 44-year-old got the jab on March 22 and later presented to Box Hill Hospital in Melbourne suffering fever and abdominal pain.
Daily Mail Australia also contacted the Blue Care Springwood Yurana Aged Care Facility for comment.
The elderly woman's death comes two days after a former governor from Papua New Guinea, Mal Kela Smith, died from Covid in a Queensland hospital.
The dual Papuan-British national was evacuated to Queensland on an emergency flight on March 28.
Mr Smith was first diagnosed in Papua New Guinea and was in intensive care in Redcliffe Hospital until he died 'from complications due to Covid-19' on Monday, Queensland Health said.
As Mr Smith was not diagnosed in Australia, he will not be counted in Queensland's official death toll, which stands at 6.
There have been no deaths from locally-acquired cases or travellers with Covid-19 in Queensland since April 18 last year.
Urgent AstraZeneca Covid vaccine probe lauched after man hospitalised
Australia's medicines regulator has begun an urgent investigation into the AstraZeneca Covid vaccine after a man was hositalised with a rare blood clotting condition. The Therapeutic Goods Administration held talks with British regulators overnight probing whether the 44-year-old's low blood platelets and 22 other similar cases in the UK are linked to the vaccine.Discussions will continue on Saturday between the Australian Health Protection Principal Committee and the Australian Technical Advisory Group on Immunisation.
Three people, including a returned overseas traveller in his 40s, are currently in intensive care with the virus in Australia.
Australia's vaccine rollout plan is based on two vaccines: an imported one made by Pfizer and BioNTech, and the other by AstraZeneca and University of Oxford.
The majority of Australians will receive the AstraZeneca vaccine, as it is being locally manufactured by CSL.
Fatigue, headaches and body aches are understood to be the most common side effects of the AstraZeneca vaccine.
Overseas there have been reports of deaths in Norway and Israel after Pfizer vaccinations, but authorities have reassured the public the claims are overstated and coincidental.
Australian Prime Minister Scott Morrison received the Pfizer vaccine, which was mainly being used in the early stages of Australia's vaccine rollout, before local production of the AstraZeneca jab began.
According to clinical trials the Pfizer vaccine prevents Covid-19 in 95 per cent of recipients.
Decision about AstraZeneca's use in Australia to be make this week
An urgent investigation was launched into the potential side effects of the Covid-19 vaccine after a Melbourne man who received the jab was hospitalised with a rare blood clotting condition. Experts have been holding talks with European regulators to determine whether the 44-year-old's low blood platelets and 22 other similar cases in the UK are linked to the vaccine. The Australian Technical Advisory Group on Immunisation (ATAGI) will convene on Wednesday to weigh up the risks and benefits of AstraZeneca jabs once further information is provided from international discussions.
The Therapeutic Goods Administration was adamant 'there is no specific risk of vaccination with the Pfizer-BioNTech Covid-19 vaccine in elderly patients'.
But the TGA did identify side effects.
More than 60 per cent of people will experience fatigue from a Pfizer dose and over 50 per cent will get a headache.
Over 30 per cent will suffer muscle pain or chills from the Pfizer vaccine and more than 20 per cent will experience joint pain.
Last week an experienced emergency room doctor claims he was floored for days by side effects from his second jab of the Pfizer coronavirus vaccine that 'shocked' him.
David Caldicott, who works at Canberra's Calvary Hospital, was among the first people in the country to get the vaccine under the government's phase 1a rollout.
Dr Caldicott had his first dose of Pfizer's vaccine in February, which he described as fairly normal with no adverse effects.
But three weeks later he received his second Pfizer dose and was so exhausted he cancelled his weekend plans and decided to stay home.
It’s Not Over for the J&J Vaccine .
A pause is just that—a pause—in which health officials can reevaluate the data at hand.Experts haven’t yet conclusively determined whether J&J’s vaccine is directly causing these strange clots, or how frequently the condition might be occurring, because they’re relying largely on people reporting their health conditions to federal agencies. Roughly 7 million doses of the vaccine have been administered so far in the United States; among them were about 1 million women under the age of 50. “I think it’s reasonable to say it is a rare event, but I don’t think we should go into false precision in this kind of situation,” Saad Omer, a vaccine expert at Yale, told me.